Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Osiris Therapeutics Inc

+ Add to Watchlist


18.1500 USD 0.0500 0.27%

As of 20:10:00 ET on 05/26/2015.

Company Profile for Osiris Therapeutics Inc (OSIR)

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

Contact Information

Osiris Therapeutics Inc

7015 Albert Einstein Drive
Columbia, MD 21046
United States
Phone: 1-443-545-1800
Fax: 1-443-545-1701

Key Executives for Osiris Therapeutics Inc (OSIR)

Lode DebrabanderePresident/CEOPhilip R Jacoby JrCFO/Treasurer/Secretary
Jonathan M Hopper "Jon"Chief Medical OfficerAlla N DanilkovitchChief Scientific Officer
Gregory I LawVP:FinanceFrank D Czworka JrVP/General Manager:Wound Care
Adrian P J MolloGeneral CounselAmanda BadilloInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil